Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

ASCLETIS-B Presents Compelling Clinical and Preclinical Data for Obesity Portfolio at ADA 2026, Reinforcing Pipeline Differentiation

Stock News
·
Jun 08

Ocumension Therapeutics (HKG:1477) About To Shift From Loss To Profit

Simply Wall St.
·
Jun 06

PEGBIO CO-B Receives First Commercialization Milestone Payment of HK$61 Million for Weipenataide from Tengrui Pharmaceutical

Stock News
·
Jun 05

Pharmaceutical Sector Rebounds, Huabao Pharma ETF Gains 2% Intraday! Margin Traders Accumulate at Lows, Hong Kong Stock Connect Innovative Drug ETF (520880) Sees Record High Margin Balance!

Deep News
·
Jun 05

ASCLETIS-B Executes Share Buyback Valued at Approximately HK$2.03 Million

Stock News
·
Jun 04

Legal Claim Against Xiangxue Pharmaceutical Filed, Additional Eligible Investors Invited

Deep News
·
Jun 04

New Legal Actions Filed for Shareholder Compensation Claims Against Two Listed Companies

Deep News
·
Jun 04

HighLight Pharmaceutical-B's Hong Kong IPO Application Lapses

Stock News
·
Jun 04

Key Figure Departs ByteDance's AI Research Unit, Eyeing Venture in AI Drug Discovery

Deep News
·
Jun 03

Fulcrum Therapeutics Halts Development of Sickle Cell Drug Due to Safety Concerns, Shares Plunge Over 50% as Company Explores Sale

Deep News
·
Jun 02

ASCLETIS-B Executes Share Buyback, Spending HK$2.06 Million on 200,000 Shares

Stock News
·
Jun 02

Morgan Stanley Adjusts Target Price for SBP GROUP, Maintains Positive Outlook

Stock News
·
Jun 01

Ark Jianke Shares Surge Over 15% Intraday Following Strategic AI Health Partnership with Tengrui Pharmaceutical

Stock News
·
Jun 01

Replimune Shares Soar 72% on Plan for Third FDA Submission of Melanoma Drug

Deep News
·
May 29

Pharmaceutical Firm Lupeng Biotech Files for Hong Kong IPO Again

Stock News
·
May 28

Ocumension Therapeutics Enrolls First Patient in Presbyopia Drug Trial

MT Newswires Live
·
May 28

Chongqing Genrix Biopharmaceutical Inks Up to RMB 1.82 Billion Licensing Deal for GR1803 with Pharma Partner

Stock News
·
May 28

OCUMENSION-B Achieves First Patient Enrollment in Phase III Trial for OT-802

Stock News
·
May 28

Ocumension reports first patient enrolled in Phase III China trial for presbyopia candidate OT-802

Bulletin Express
·
May 28

Ocumension enrolls first patient in China Phase III trial of presbyopia drug OT-802

Reuters
·
May 28